Physician profile
Mary E Price
NPI 1346365319
$1,161.81
in general payments reported to CMS, 2019-2025
20 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $326 · 2020: $95.68 · 2021: $237 · 2022: $105 · 2023: $99.94 · 2024: $149 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $398.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $517.35 | 2019-2024 | Veozah |
| Lilly USA, LLC | $95.53 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $61.37 | 2019-2021 | |
| Novo Nordisk INC | $59.40 | 2023-2024 | Ozempic, Rybelsus |
| Pfizer INC. | $55.11 | 2019-2025 | |
| Abbvie INC. | $47.84 | 2022-2023 | Vraylar, Qulipta, Ubrelvy |
| Intuitive Surgical, INC. | $40.92 | 2024 | |
| Glaxosmithkline, LLC. | $37.65 | 2019-2025 | Trelegy Ellipta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.46 | 2019-2020 | |
| Amarin Pharma, INC. | $30.13 | 2019 | |
| Sumitomo Pharma America, INC. | $28.18 | 2025 | Gemtesa |
| Abbott Laboratories | $24.19 | 2025 | Freestyle Libre 3 |
| Inspire Medical Systems, INC. | $21.56 | 2025 | Inspire |
| Paratek Pharmaceuticals, INC. | $21.47 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.37 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $14.67 | 2023 | Clydesdale Ptc Spinal System |
| Currax Pharmaceuticals LLC | $13.26 | 2021 | |
| Janssen Pharmaceuticals, INC | $11.94 | 2020 | |
| Mannkind Corporation | $11.80 | 2019 | |
| Merck Sharp & Dohme LLC | $11.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Price listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.